University Medical Center Mainz | Dermatology Clinical Research Center
Status
Conditions
Treatments
About
Evaluate the safety and efficacy of Medtronic Intrepid™ TMVR TF System in patients with moderate-to-severe or severe symptomatic mitral regurgitation, or moderate symptomatic mitral regurgitation combined with mitral stenosis in the presence of MAC who, by agreement of the local site multidisciplinary heart team experienced in mitral valve therapies, are unsuitable for treatment with approved transcatheter repair or surgical mitral valve intervention.
Full description
Prospective, single-arm, multi-center, interventional, pre-market trial
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
400 participants in 1 patient group
Loading...
Central trial contact
Hanne Gonnissen, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal